260
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of reproductive toxicity in male rats treated with novel synthesized ruthenium(II) and gold(I)-NHC complexes

, , &
Pages 40-46 | Received 21 Mar 2011, Accepted 16 May 2011, Published online: 26 Aug 2011
 

Abstract

In this study, we aimed to determine the reproductive toxicity in rat induced by ruthenium(II)-NHC (RuII) and gold(I)-NHC (AuI) complexes that have anticarcinogenic effects. For this purpose, 35 Sprague–Dawley rats were randomly divided into 5 equal groups. In control group, rats treated with saline, RuII, and AuI complexes were intraperitoneally given high (10 mg/kg) and low (5 mg/kg) doses to rats via a one-time administration. The animals were sacrificed, and testis tissues were taken on Day 10 of the drug administration for the determination of the biochemical, histopathological, spermatological, and hormonal parameters. It was determined that treatment group that was subjected to treatment using both RuII and AuI complexes significantly caused oxidative, histopathological, spermatological, and hormonal damage compared to control group. However, the sexual and accessory organ weight did not significantly change when compared to control. In addition, it was shown that AuI treatment generally caused more adverse effects than RuII treatment in a dose-dependent manner. In conclusion, when these synthesized compounds are used for the treatment of cancer, they could cause toxic effects on male reproductive system and lead to infertility. However, RuII complex is a more preferable option in cancer treatment, particularly in terms of user safety.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.